Eosinophil cationic protein in feces: Reference values in healthy and atopic individuals and patients with digestive diseases

Isabel Garcia-Rubio, Consuelo Martinez-Cocera, Luis Zayas

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Eosinophil cationic protein (ECP) is a good indicator of eosinophilic activity and turnover, serving as a marker of activity in allergic and gastrointestinal diseases characterized by predominantly eosinophilic tissue infiltration. Our aim was to compare ECP levels in feces from healthy individuals, atopic patients, and patients with digestive diseases and establish reference values for this clinical setting. Thirty-nine healthy adults, 28 atopic patients, and 14 patients with digestive diseases were enrolled. The atopic patients had been diagnosed with allergic rhinoconjunctivitis and/or asthma. ECP concentrations in the supernatants from processed feces adjusted for semidry weight (μg/g feces) were determined by fluorescent enzyme immunoassay. Between-group comparisons were performed of medians and interquartile ranges (IQR) by nonparametric tests. Median (IQR) ECP levels were 8.16 (4.11-17.61), 10.83 (5.18-18.49), and 13.02 (5.17-21.97) μg/g feces in controls, atopic patients, and digestive disease patients, respectively; mean (SD) levels were 14.53 (13.77), 13.93 (11.30), and 16.51 (14.79) μg/g of feces. No significant differences in the medians were observed between the atopic group and controls (p = 0.725), the atopic group and digestive disease patients (p = 0.523), or the controls versus the digestive disease patients (p = 0.694). We provide reference values for ECP levels in feces for normal and atopic adults. There is considerable variability in ECP levels in feces and the median levels are similar in healthy and atopic individuals and patients with digestive diseases.

Original languageEnglish (US)
Pages (from-to)468-471
Number of pages4
JournalAllergy and Asthma Proceedings
Volume28
Issue number4
DOIs
StatePublished - Jul 2007
Externally publishedYes

Fingerprint

Eosinophil Cationic Protein
Feces
Reference Values
Gastrointestinal Diseases
Immunoenzyme Techniques
Asthma

Keywords

  • Atopic hypersensitivity
  • Digestive diseases
  • Eosinophil cationic protein
  • Feces
  • Fluorescent enzyme immunoassay
  • Reference values
  • Stool sample

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Eosinophil cationic protein in feces : Reference values in healthy and atopic individuals and patients with digestive diseases. / Garcia-Rubio, Isabel; Martinez-Cocera, Consuelo; Zayas, Luis.

In: Allergy and Asthma Proceedings, Vol. 28, No. 4, 07.2007, p. 468-471.

Research output: Contribution to journalArticle

Garcia-Rubio, Isabel ; Martinez-Cocera, Consuelo ; Zayas, Luis. / Eosinophil cationic protein in feces : Reference values in healthy and atopic individuals and patients with digestive diseases. In: Allergy and Asthma Proceedings. 2007 ; Vol. 28, No. 4. pp. 468-471.
@article{ae3186a4b05b412ab2a8b70b8deed785,
title = "Eosinophil cationic protein in feces: Reference values in healthy and atopic individuals and patients with digestive diseases",
abstract = "Eosinophil cationic protein (ECP) is a good indicator of eosinophilic activity and turnover, serving as a marker of activity in allergic and gastrointestinal diseases characterized by predominantly eosinophilic tissue infiltration. Our aim was to compare ECP levels in feces from healthy individuals, atopic patients, and patients with digestive diseases and establish reference values for this clinical setting. Thirty-nine healthy adults, 28 atopic patients, and 14 patients with digestive diseases were enrolled. The atopic patients had been diagnosed with allergic rhinoconjunctivitis and/or asthma. ECP concentrations in the supernatants from processed feces adjusted for semidry weight (μg/g feces) were determined by fluorescent enzyme immunoassay. Between-group comparisons were performed of medians and interquartile ranges (IQR) by nonparametric tests. Median (IQR) ECP levels were 8.16 (4.11-17.61), 10.83 (5.18-18.49), and 13.02 (5.17-21.97) μg/g feces in controls, atopic patients, and digestive disease patients, respectively; mean (SD) levels were 14.53 (13.77), 13.93 (11.30), and 16.51 (14.79) μg/g of feces. No significant differences in the medians were observed between the atopic group and controls (p = 0.725), the atopic group and digestive disease patients (p = 0.523), or the controls versus the digestive disease patients (p = 0.694). We provide reference values for ECP levels in feces for normal and atopic adults. There is considerable variability in ECP levels in feces and the median levels are similar in healthy and atopic individuals and patients with digestive diseases.",
keywords = "Atopic hypersensitivity, Digestive diseases, Eosinophil cationic protein, Feces, Fluorescent enzyme immunoassay, Reference values, Stool sample",
author = "Isabel Garcia-Rubio and Consuelo Martinez-Cocera and Luis Zayas",
year = "2007",
month = "7",
doi = "10.2500/aap.2007.28.3025",
language = "English (US)",
volume = "28",
pages = "468--471",
journal = "Allergy and Asthma Proceedings",
issn = "1088-5412",
publisher = "OceanSide Publications Inc.",
number = "4",

}

TY - JOUR

T1 - Eosinophil cationic protein in feces

T2 - Reference values in healthy and atopic individuals and patients with digestive diseases

AU - Garcia-Rubio, Isabel

AU - Martinez-Cocera, Consuelo

AU - Zayas, Luis

PY - 2007/7

Y1 - 2007/7

N2 - Eosinophil cationic protein (ECP) is a good indicator of eosinophilic activity and turnover, serving as a marker of activity in allergic and gastrointestinal diseases characterized by predominantly eosinophilic tissue infiltration. Our aim was to compare ECP levels in feces from healthy individuals, atopic patients, and patients with digestive diseases and establish reference values for this clinical setting. Thirty-nine healthy adults, 28 atopic patients, and 14 patients with digestive diseases were enrolled. The atopic patients had been diagnosed with allergic rhinoconjunctivitis and/or asthma. ECP concentrations in the supernatants from processed feces adjusted for semidry weight (μg/g feces) were determined by fluorescent enzyme immunoassay. Between-group comparisons were performed of medians and interquartile ranges (IQR) by nonparametric tests. Median (IQR) ECP levels were 8.16 (4.11-17.61), 10.83 (5.18-18.49), and 13.02 (5.17-21.97) μg/g feces in controls, atopic patients, and digestive disease patients, respectively; mean (SD) levels were 14.53 (13.77), 13.93 (11.30), and 16.51 (14.79) μg/g of feces. No significant differences in the medians were observed between the atopic group and controls (p = 0.725), the atopic group and digestive disease patients (p = 0.523), or the controls versus the digestive disease patients (p = 0.694). We provide reference values for ECP levels in feces for normal and atopic adults. There is considerable variability in ECP levels in feces and the median levels are similar in healthy and atopic individuals and patients with digestive diseases.

AB - Eosinophil cationic protein (ECP) is a good indicator of eosinophilic activity and turnover, serving as a marker of activity in allergic and gastrointestinal diseases characterized by predominantly eosinophilic tissue infiltration. Our aim was to compare ECP levels in feces from healthy individuals, atopic patients, and patients with digestive diseases and establish reference values for this clinical setting. Thirty-nine healthy adults, 28 atopic patients, and 14 patients with digestive diseases were enrolled. The atopic patients had been diagnosed with allergic rhinoconjunctivitis and/or asthma. ECP concentrations in the supernatants from processed feces adjusted for semidry weight (μg/g feces) were determined by fluorescent enzyme immunoassay. Between-group comparisons were performed of medians and interquartile ranges (IQR) by nonparametric tests. Median (IQR) ECP levels were 8.16 (4.11-17.61), 10.83 (5.18-18.49), and 13.02 (5.17-21.97) μg/g feces in controls, atopic patients, and digestive disease patients, respectively; mean (SD) levels were 14.53 (13.77), 13.93 (11.30), and 16.51 (14.79) μg/g of feces. No significant differences in the medians were observed between the atopic group and controls (p = 0.725), the atopic group and digestive disease patients (p = 0.523), or the controls versus the digestive disease patients (p = 0.694). We provide reference values for ECP levels in feces for normal and atopic adults. There is considerable variability in ECP levels in feces and the median levels are similar in healthy and atopic individuals and patients with digestive diseases.

KW - Atopic hypersensitivity

KW - Digestive diseases

KW - Eosinophil cationic protein

KW - Feces

KW - Fluorescent enzyme immunoassay

KW - Reference values

KW - Stool sample

UR - http://www.scopus.com/inward/record.url?scp=34548638319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548638319&partnerID=8YFLogxK

U2 - 10.2500/aap.2007.28.3025

DO - 10.2500/aap.2007.28.3025

M3 - Article

C2 - 17883916

AN - SCOPUS:34548638319

VL - 28

SP - 468

EP - 471

JO - Allergy and Asthma Proceedings

JF - Allergy and Asthma Proceedings

SN - 1088-5412

IS - 4

ER -